Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factor

Journal of Orthopaedic Research (Impact Factor: 2.88). 08/2001; 19(5):935 - 944. DOI: 10.1016/S0736-0266(01)00024-9

ABSTRACT Chondrogenesis is an essential component of endochondral fracture healing, though the molecular and cellular events by which it is regulated have not been fully elucidated. In this study, we used a rat model of closed fracture healing to determine the spatial and temporal expression of genes for cartilage-specific collagens. Furthermore, to determine the effects of basic fibroblast growth factor (bFGF) on chondrogenesis in fracture healing, we injected 100 μg recombinant human bFGF into the fracture site immediately after fracture.In normal calluses, pro-(II) collagen mRNA (COL2A1) was detected in proliferative chondrocytes beginning on day 4 after the fracture, and pro-(X) collagen mRNA (COL10A1) in hypertrophic chondrocytes beginning on day 7. In FGF-injected calluses, the cartilage enlarged in size significantly. On day 14, both COL2A1-and COL10A1-expressing cells were more widely distributed, and the amounts of COL2A1 and COL10A1 mRNAs were both approximately 2-fold increased when compared with uninjected fractures. Temporal patterns of expression for these genes were, however, identical to those found in normal calluses. The number of proliferating cell nuclear antigen-positive cells was increased in the non-cartilaginous area in the bFGF-injected calluses by day 4.The present molecular analyses demonstrate that a single injection of bFGF enhances the proliferation of chondroprogenitor cells in fracture callus, and thus contributes to the formation of a larger cartilage. However, maturation of chondrocytes and replacement of the cartilage by osseous tissue are not enhanced by exogenous bFGF, and this results in the prolonged cartilaginous callus phase. We conclude that, in the healing of closed fractures of long bones, exogenous bFGF has a capacity to enlarge the cartilaginous calluses, but not to induce more rapid healing. © 2001 Orthopaedic Research Society. Punlished by Elsevier Science Ltd. All rights reserved.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Strategies to control the delivery of growth factors are critically important in the design of advanced biomaterials. In this study we investigated the binding and release of fibroblast growth factor 2 (FGF-2) to/from a biohybrid hydrogel matrix by four independent analytical methods: radioisotope and fluorescence labeling, amino acid analysis and Enzyme-Linked Immunosorbent Assays (ELISA). The compared analyses provided qualitatively similar uptake characteristics while the results of the FGF-2 quantification strongly depended on the particular experimental conditions. The release kinetics of FGF-2 from the gels could be monitored sensitively by (125)I labeling and by ELISA-techniques. The latter method was concluded to be advantageous since it permits the application of unmodified ("native") growth factors.
    Journal of Materials Science Materials in Medicine 10/2009; 21(3):915-23. · 2.14 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Most studies have focused on the association between diabetes mellitus (DM) and impaired osseous healing, but there is also evidence that diabetes impairs cartilage formation during fracture healing. To investigate the molecular mechanisms by which diabetes affects endochondral ossification, experiments were performed in a model of rat closed fracture healing complicated with diabetes. Diabetic rats were created by a single intravenous injection of streptozotocin (STZ), while controls were treated with vehicle alone. Fractures were made 2 weeks after STZ injection. Animals were killed at 4, 7, 10, 14, 21, 28 and 42 days following fracture, and samples were subject to radiographic, histological and molecular analyses. In the DM group, a significantly smaller cartilaginous callus was formed compared with controls throughout healing, with the cartilage area being reduced rapidly after day 14. When the bone union rate was evaluated radiographically on day 28, DM calluses exhibited a lower rate than controls. However, when evaluated on day 42, both groups showed an equivalent union rate. Cellular proliferation of chondroprogenitor cells and proliferating chondrocytes in soft calluses of the DM group was significantly reduced during early stages of healing (days 4 and 7), but no longer reduced thereafter. Moreover, expression levels of collagen type II, type X and osteopontin (OPN) were constantly low in the DM group. These results show the molecular basis for diminished cartilage formation and delayed union in fracture healing of the STZ-induced diabetic rats.
    Bone 09/2008; 43(5):832-9. · 4.46 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Safe, effective methods for bone and cartilage regeneration are needed to reverse bone loss caused by trauma, disease, tumor resection and osteoarthritis. Unfortunately, all current or emerging therapies have serious limitations. As will be developed in this chapter, gene therapy offers a promising approach for musculoskeletal regeneration because it can mimic the natural biological processes of bone development and fracture healing. This chapter will provide an overview of normal skeletal development and fracture repair, and describe how gene therapy in combination with tissue engineering can model critical aspects of these natural processes. Current gene therapy approaches for bone and cartilage regeneration will then be summarized, as well as recent work where combinatorial gene therapy is used to express groups of molecules that synergistically interact. Lastly, proposed new directions will be described that incorporate regulated gene expression and cells seeded in precise three-dimensional confi gurations on synthetic scaffolds to control both temporal and spatial distribution of regenerative factors. These and related approaches may eventually allow us to achieve the ultimate goal of bone tissue engineering: to reconstruct entire bones with associated joints, ligaments or sutures.